Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Mesenchymal stem cells have been recently described to localize to breast carcinomas, where they integrate into the tumour-associated stroma. However, the involvement of mesenchymal stem cells (or their derivatives) in tumour pathophysiology has not been addressed. Here, we demonstrate that bone-marrow-derived human mesenchymal stem cells, when mixed with otherwise weakly metastatic human breast carcinoma cells, cause the cancer cells to increase their metastatic potency greatly when this cell mixture is introduced into a subcutaneous site and allowed to form a tumour xenograft. The breast cancer cells stimulate de novo secretion of the chemokine CCL5 (also called RANTES) from mesenchymal stem cells, which then acts in a paracrine fashion on the cancer cells to enhance their motility, invasion and metastasis. This enhanced metastatic ability is reversible and is dependent on CCL5 signalling through the chemokine receptor CCR5. Collectively, these data demonstrate that the tumour microenvironment facilitates metastatic spread by eliciting reversible changes in the phenotype of cancer cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MSC can be mobilized and recruited to active tumor sites, where they can incorporate into the tumor’s microenvironment [5, 68, 100–103].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [100]
In the citing paper
“CCL5 can be secreted by both BM-MSC and ASC [100, 144] and displays pro-proliferative activities on breast cancer cell lines [145, 146].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [100]
In the citing paper
“Another MSC-secreted pro-metastasis cytokine, CCL5 (RANTES), can be secreted upon interaction with cancer cells and is associated with tumor progression and invasion in various cancers [73, 87, 100, 142–144].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [100]
In the citing paper
“The injection of bone marrow-derived MSCs into tumour-bearing mice has demonstrated that they can become CAFs40”
From A framework for advancing our understanding of cancer-associated fibroblasts (2020) · cites this paper as [40]
In the citing paper
“CAFs comprise the majority of cell types within the TME, and their reciprocal interactions with cancer cells have been well documented (Whiteside, 2008; Hazlehurst et al., 2003; Karnoub et al., 2007).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Karnoub et al., 2007
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Self-citationCreation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
Self-citationCancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
Bissell, M. J., & Radisky, D. (2001) · Nature Reviews Cancer · doi:10.1038/35094059 · Cited by 2,180
Molecular characterization of the tumor microenvironment in breast cancer
Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J., Huang, H., Porter, D., Hu, M., Chin, L., Richardson, A., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.010 · Cited by 1,299
Self-citationHuman Bone Marrow–Derived Mesenchymal Stem Cells in the Treatment of Gliomas
Nakamizo, A., Marini, F., Amano, T., Khan, A., Studeny, M., Gumin, J., Chen, J., Hentschel, S., Vecil, G., Dembinski, J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1874 · Cited by 1,035
(2002) · PubMed · Cited by 903
Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells
Elenbaas, B., Spirio, L., Koerner, F., Fleming, M. D., Zimonjic, D. B., Donaher, J. L., Popescu, N. C., Hahn, W. C., & Weinberg, R. A. (2001) · Genes & Development · doi:10.1101/gad.828901 · Cited by 878
Self-citation
Cited by
Items 901–1,000 of 1,024
Systematic review: The oncological safety of adipose fat transfer after breast cancer surgery
Waked, K., Colle, J., Doornaert, M. A. J., Cocquyt, V., & Blondeel, P. N. (2016) · The Breast · doi:10.1016/j.breast.2016.11.001 · Cited by 80
Cancer Risk after Fat Transfer: A Multicenter Case-Cohort Study
Myckatyn, T. M., Wagner, I. J., Mehrara, B. J., Crosby, M. A., Park, J. E., Qaqish, B. F., Moore, D. T., Busch, E. L., Silva, A. K., Kaur, S., et al. (2016) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000002838 · Cited by 79
“62) 25 25 TNM stage I 585 (49) 77 (34) 508 (52) II 448 (37) 92 (41) 356 (37) III 164 (14) 56 (25) 108 (11) Receptors HER2Neu+ 215 (20) 29 (13) 205 (22) ER+ 875 (74) 134 (60) 741 (78) PR+ 713 (61) 101 (46) 612 (64) Treatment Adjuvant radiation therapy 319 (27) 110 (49) 209 (22) Adjuvant chemotherapy 689 (58) 153 (68) 5…”
Xie, H.-Y., Shao, Z., & Li, D. (2017) · 癌症:英文版 · doi:10.1186/s40880-017-0202-y · Cited by 80
“The underlying mechanism for these observations is that MSC-secreted chemokine CCL5 acts in a paracrine manner on breast cancer cells to enhance their motility, invasion, and metastasis [56].”
BackgroundThe role of mesenchymal stem cells in cancer development
Yagi, H., & Kitagawa, Y. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00261 · Cited by 72
“However, Karnoub et al. (2007) suggested that MSCs have a supportive effect on tumor progression showing that co-injection of MSCs with cells from a breast cancer cell-line led to a higher degree of metastasis, but this effect was not significant in local tumor growth.”
BackgroundInfluentialLim, E.-J., Kim, S., Oh, Y., Suh, Y., Kaushik, N., Lee, J.-H., Lee, H., Kim, M.-J., Park, M. J., Kim, R.-K., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa064 · Cited by 78
Non-coding RNAs in necroptosis, pyroptosis and ferroptosis in cancer metastasis
Liu, Y., Chen, Q., Zhu, Y., Wang, T., Ye, L., Han, L., Yao, Z., & Yang, Z. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00596-9 · Cited by 78
“In recent years, non-coding RNA has participated in mediating multiple processes in tumor metastasis, such as epithelial–mesenchymal cell transformation and tumor angiogenesis [5].”
BackgroundZhao, M., Sachs, P. C., Wang, X., Dumur, C. I., Idowu, M. O., Robila, V., Francis, M. P., Ware, J., Beckman, M., Rizki, A., et al. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.20561 · Cited by 72
Ben‐Baruch, A. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0094-3 · Cited by 78
Hu, Q., Guo, C. H., Li, Y., Aronow, B. J., & Zhang, J. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01365-10 · Cited by 78
“Given the highly invasive and stroma-like phenotype of MDA-MB-231 cells (22) and the importance of stromal cells in the development of breast cancer metastasis (10, 20), we asked whether the level of expression of LMO7 can also be increased in the stroma of invasive breast carcinomas.”
BackgroundNiche contributions to oncogenesis: emerging concepts and implications for the hematopoietic system
Raaijmakers, M. H. G. P. (2011) · Haematologica · doi:10.3324/haematol.2010.028035 · Cited by 79
“Further evidence to support a role for stromal cell types in breast cancer cell progression is provided by the demonstration that bone marrow derived human mesenchymal stem cells cause otherwise weakly metastatic human breast carcinoma cells to greatly increase their metastatic potency.(40) In this xenograft model, th…”
BackgroundCurrent Perspectives Regarding Stem Cell-Based Therapy for Liver Cirrhosis
Kwak, K.-A., Cho, H.-J., Yang, J.-Y., & Park, Y.-S. (2018) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2018/4197857 · Cited by 69
“Furthermore, the posttransplantation incidence of hepatocellular carcinoma was not increased despite the enduring concern [68, 274, 275].”
BackgroundReciprocal modulation of mesenchymal stem cells and tumor cells promotes lung cancer metastasis
Fregni, G., Quinodoz, M., Möller, E., Vuille, J., Galland, S., Fusco, C., Martin, P., Letovanec, I., Provero, P., Rivolta, C., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.02.017 · Cited by 74
“They can also differentiate in situ into a variety of mesenchymal lineages (Bergfeld and DeClerck, 2010; Cuiffo and Karnoub, 2012) and have been suggested to promote tumor metastasis (Karnoub et al., 2007; Koh and Kang, 2012) based on models using BM-MSCs and cancer cell lines (Bergfeld and DeClerck, 2010).”
Circulating Tumor Cell-Neutrophil Tango along the Metastatic Process
Saini, M., Szczerba, B. M., & Aceto, N. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1972 · Cited by 77
“The immune infiltrate includes pro-angiogenic TAMs (42) and tolerogenic mediators, that is, T regulatory cells but also mesenchymal stem cells and immature stromal cells (46, 47).”
BackgroundChemokines and their receptors: predictors of the therapeutic potential of mesenchymal stromal cells
Cuesta‐Gomez, N., Graham, G. J., & Campbell, J. D. M. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02822-5 · Cited by 77
“This axis is important in MSC mediated tumor invasion and metastasis due to the increased secretion of the inflammatory chemokine CCL5 by MSCs [61, 62].”
BackgroundCadherin-11 in poor prognosis malignancies and rheumatoid arthritis: common target, common therapies
Assefnia, S., Dakshanamurthy, S., Auvil, J. M. G., Hampel, C., Anastasiadis, P. Z., Kallakury, B., Üren, A., Foley, D., Brown, M. L., Shapiro, L. S., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1538 · Cited by 77
“Breast tumor stroma contains mesenchymal stem cells that express factors vital for malignant progression [15].”
BackgroundNarayanan, R., Ahn, S., Cheney, M. D., Yepuru, M., Miller, D. D., Steiner, M. S., & Dalton, J. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103202 · Cited by 78
“Invasion of other organs arises due to paracrine factors secreted during epithelial: MSC interaction [26].”
BackgroundInfluentialALK receptor activation, ligands and therapeutic targeting in glioblastoma and in other cancers
Wellstein, A. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00192 · Cited by 77
“No significant changes were seen in a further analysis of breast tissues (Karnoub et al., 2007).”
BackgroundMesenchymal stem cells ameliorate the histopathological changes in a murine model of chronic asthma
Fırıncı, F., Karaman, M., Baran, Y., Bağrıyanık, A., Ayyıldız, Z. A., Kıray, M., Kozanoğlu, İ., Yılmaz, O., Uzuner, N., & Karaman, Ö. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.03.009 · Cited by 77
Castells, M., Milhas, D., Gandy, C., Thibault, B., Rafii, A., Delord, J., & Couderc, B. C. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.384 · Cited by 77
“Such MSCs are found to stimulate tumour growth, enhance angiogenesis and promote metastasis formation through the release of a large spectrum of growth factors and cytokines.(6,8,9) Little is known on the mechanism leading to the transformation of a BM-MSC to a CA-MSC.”
BackgroundBalyasnikova, I. V., Ferguson, S. D., Sengupta, S., Han, Y., & Lesniak, M. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009750 · Cited by 77
“These data are in an agreement with recent study demonstrating the absence of the growth-promoting effect of MSCs on glial brain tumors [31], which was shown in other types of tumors [40,41].”
ResultPersonalized therapies in the cancer "omics" era
Ocaña, A., & Pandiella, A. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-202 · Cited by 78
“In other neoplastic pathologies such as breast cancer, mesenchymal stem cells have been shown to promote metastatic dissemination of the tumoral cells [52].”
BackgroundCCL5-deficiency enhances intratumoral infiltration of CD8+ T cells in colorectal cancer
Zhang, S., Zhong, M., Wang, C., Xu, Y., Gao, W.-Q., & Zhang, Y. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0796-2 · Cited by 68
BMPR2 loss in fibroblasts promotes mammary carcinoma metastasis via increased inflammation
Pickup, M. W., Hover, L. D., Polikowsky, E. R., Chytil, A., Gorska, A. E., Novitskiy, S. V., Moses, H. L., & Owens, P. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.08.004 · Cited by 76
“CCL5 derived from the stroma has been demonstrated to drive breast cancer metastasis (Karnoub et al., 2007).”
BackgroundXu, Z., Liu, C., Zhao, Q., Lü, J., Ding, X., Luo, A., He, J., Wang, G., Li, Y., Cai, Z., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104628 · Cited by 76
Nandy, S., Arumugam, A., Subramani, R., Pedroza, D. A., Hernandez, K. R., Saltzstein, E. C., & Lakshmanaswamy, R. (2015) · Oncotarget · doi:10.18632/oncotarget.3953 · Cited by 76
“LIFR is a known tumor/metastatic suppressor [6] for breast cancer and its downregulation in breast cancer has been demonstrated [17-19].”
BackgroundToward MSC in Solid Organ Transplantation: 2008 Position Paper of the MISOT Study Group
Dahlke, M. H., Hoogduijn, M. J., Eggenhofer, E., Popp, F., Renner, P., Slowik, P., Rosenauer, A., Piso, P., Geissler, E. K., Lange, C., et al. (2009) · Transplantation · doi:10.1097/tp.0b013e3181b4425a · Cited by 76
“Numerous other studies demonstrated a tropism of MSC towards tumor stroma, where both their angiogenic and immunomodulatory properties can potentially promote tumor growth (41) and metastases (42).”
BackgroundPino, M. S., Balsamo, M., Modugno, F. D., Mottolese, M., Alessio, M., Melucci, E., Milella, M., McConkey, D. J., Philippar, U., Gertler, F. B., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0436 · Cited by 76
Dittmer, A., Hohlfeld, K., Lützkendorf, J., Müller, L. P., & Dittmer, J. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0089-0 · Cited by 76
“The chemokine CCL5 has been shown to be secreted by hMSCs and to activate migration of MDA-MB-231 cells [9].”
Backgroundvan den Hoogen, C., van der Horst, G., Cheung, H., Buijs, J. T., Pelger, R. C. M., & van der Pluijm, G. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.07.011 · Cited by 76
Responsiveness of Stromal Fibroblasts to IFN-γ Blocks Tumor Growth via Angiostasis
Lu, Y., Yang, W., Qin, C., Zhang, L., Deng, J., Liu, S., & Qin, Z. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901073 · Cited by 69
“The emerging role of stem cells within the tumor stroma has been emphasized in recent years (45, 48).”
BackgroundIser, I. C., Ceschini, S. M., Onzi, G. R., Bertoni, A. P. S., Lenz, G., & Wink, M. R. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9585-4 · Cited by 76
“These results demonstrate the importance of the tumor microenvironment and that cancer cells can respond in a transient way to signals received from their stromal microenvironment [62].”
BackgroundStem cell-based therapies for tumors in the brain: are we there yet?
Shah, K. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now096 · Cited by 76
Choi, S., Yu, J., Park, A., Dubon, M. J., Do, J., Kim, Y. J., Nam, D., Noh, J., & Park, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-48190-5 · Cited by 77
Kamat, P., Schweizer, R., Kaenel, P., Salemi, S., Calcagni, M., Giovanoli, P., Gorantla, V. S., Eberli, D., Andres, A., & Plock, J. A. (2015) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000001321 · Cited by 77
Mesenchymal stromal cells as cancer promoters
Antoon, R., Overdevest, N., Saleh, A. H., & Keating, A. (2024) · Oncogene · doi:10.1038/s41388-024-03183-1 · Cited by 75
Ghosh, D., Peña, C. M., Quach, N. D., Xuan, B., Lee, A. H., & Dawson, M. (2020) · Journal of Cell Science · doi:10.1242/jcs.232470 · Cited by 76
“, 2008) and drive the formation of more invasive cancer cell phenotypes (Karnoub et al., 2007; McAndrews et al., 2015b).”
BackgroundOrgan-specific migration of mesenchymal stromal cells: Who, when, where and why?
Cornelissen, A. S., Maijenburg, M. W., Nolte, M. A., & Voermans, C. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.06.019 · Cited by 75
“[112] Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, et al.”
BackgroundLI, T., ZHANG, C., DING, Y., ZHAI, W., LIU, K., BU, F., TU, T., SUN, L., ZHU, W., ZHOU, F., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.4109 · Cited by 73
“The mutual interactions of tumor cells and stromal cells through direct contact to various cytokines and chemokines in a paracrine manner are thought to modulate tumor progression (6-8).”
BackgroundCC Chemokine Receptor 5: The Interface of Host Immunity and Cancer
de Oliveira, C. E. C., Oda, J. M. M., Guembarovski, R. L., de Oliveira, K. B., Ariza, C. B., Neto, J. S., Hirata, B. K. B., & Watanabe, M. A. E. (2014) · Disease Markers · doi:10.1155/2014/126954 · Cited by 75
“Bone-marrow-derived mesenchymal stem cells have been found to integrate into the tumor-associated stromal and secrete CCL5 which then acts in a paracrine way on the cancer cells to enhance their invasion [53].”
BackgroundOncosuppressive functions of decorin
Neill, T., Schaefer, L., & Iozzo, R. V. (2015) · Molecular & Cellular Oncology · doi:10.4161/23723556.2014.975645 · Cited by 75
Stat3 Mediates Expression of Autotaxin in Breast Cancer
Azare, J., Doane, A., Leslie, K., Chang, Q., Berishaj, M., Nnoli, J., Mark, K., Al-Ahmadie, H., Gerald, W., Hassimi, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027851 · Cited by 70
“Stat3 in conjunction with NF-kB is a transcriptional regulator of the chemokine RANTES which was recently shown to be a potent mediator of metastatic spread of breast cancer cells [78,79].”
BackgroundMa, M., Ye, J. Y., Deng, R., Dee, C. M., & Chan, G. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.06.028 · Cited by 75
Emerging therapeutic targets in metastatic progression: A focus on breast cancer
Li, Z., & Kang, Y. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.03.003 · Cited by 75
“The therapeutic potential of targeting MSCs in mBC warrants further investigations as MSCs could be either tumor-promoting or tumorsuppressing depending on different environmental inflammatory conditions (Kim and Cho, 2013).”
BackgroundInfluentialMDA-9/syntenin: a positive gatekeeper of melanoma metastasis
Swadesh, K. D. (2011) · Frontiers in bioscience · doi:10.2741/3911 · Cited by 75
Pelizzo, G., Veschi, V., Mantelli, M., Croce, S., Benedetto, V. D., D’Angelo, P., Maltese, A., Catenacci, L., Apuzzo, T., Scavo, E., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-5082-2 · Cited by 74
Jiao, X., Wang, M., Zhang, Z., Li, Z., Ni, D., Ashton, A. W., Tang, H., Speicher, D. W., & Pestell, R. G. (2021) · Breast Cancer Research · doi:10.1186/s13058-021-01391-1 · Cited by 74
“CCR5 siRNA did not reduce the metastatic phenotype of MDA-MB-231 cells in the absence of additional MDSC [52], endothelial cells produce CCL5, and augmented breast cancer metastasis in another study [49].”
BackgroundInfluentialTargeting the cytoskeleton against metastatic dissemination
Ruggiero, C., & Lalli, E. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09936-0 · Cited by 74
Control of cancer formation by intrinsic genetic noise and microenvironmental cues
Brock, A., Krause, S., & Ingber, D. E. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3959 · Cited by 74
Emerging roles of the tumor-associated stroma in promoting tumor metastasis
Horimoto, Y., Polanska, U. M., Takahashi, Y., & Orimo, A. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.20631 · Cited by 75
“Similarly, CCL5 chemokine secreted by mesenchymal stem cells (MSCs) enhances invasion and metastasis of breast carcinoma cells by activating the CCR5 receptors on these cells.(16) Caveolin-1 (Cav1) expressed on carcinoma-associated fibroblasts (CAFs) facilitates tumor invasion through the force-dependent architectural…”
BackgroundBone Marrow Microenvironment and Tumor Progression
Chantrain, C. F., Féron, O., Marbaix, É., & DeClerck, Y. A. (2008) · Cancer Microenvironment · doi:10.1007/s12307-008-0010-7 · Cited by 77
“Weinberg’s laboratory has shown for example that tumor cells stimulate the expression of chemokine CCL5 (RANTES) in mesenchymal stem cells, which then acts in a paracrine manner to enhance tumor cell motility, invasion and the formation of distant metastasis [58].”
BackgroundÖzdemir, B. C., Hensel, J., Secondini, C., Wetterwald, A., Schwaninger, R., Fleischmann, A., Raffelsberger, W., Poch, O., Delorenzi, M., Temanni, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114530 · Cited by 74
“9% of the OB-BMST and shares 88 genes with signatures obtained from primary MCa [12, 26–29] and PCa [29–33], known for their high propensity to metastasize to bone (osteotropism) [4, 5] (Fig.”
BackgroundKrohn, A., Ahrens, T. D., Yalcin, A., Plönes, T., Wehrle, J., Taromi, S., Wollner, S., Follo, M., Brabletz, T., Mani, S. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100249 · Cited by 74
“Changes from E-cadherin expression towards Vimentin expression is a hallmark characteristic of EMT [23,24].”
BackgroundMesenchymal stem cells hold promise for regenerative medicine
Wang, S., Qu, X., & Zhao, R. C. (2011) · Frontiers of Medicine · doi:10.1007/s11684-011-0164-4 · Cited by 74
“[47] co-injected bone marrowderived human MSCs with green fluorescent protein-labeled human breast cancer cells MCF/Ras into immunocompromised mice, and found that MSCs accelerate breast tumor growth, as well as cancer metastases.”
BackgroundXu, X., Zhang, X., Wang, S., Qian, H., Zhu, W., Cao, H., Wang, M., Chen, Y., & Xu, W. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0908-6 · Cited by 74
“Moreover, MSCs, as a part of tumor stromal microenvironment, can secrete cytokines and chemokines to affect the growth and metastasis of tumor cells (Zhu et al. 2005; Karnoub et al. 2007).”
Kansy, B., Dissmann, P. A., Hemeda, H., Bruderek, K., Westerkamp, A. M., Jagalski, V., Schuler, P. J., Kansy, K., Lang, S., Dumitru, C. A., et al. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt484 · Cited by 76
“Indeed, a number of recent studies demonstrated that MSC enhanced tumor growth and metastasis in several types of cancer [9,18-23].”
BackgroundThe role of inflammation in progression of breast cancer: Friend or foe? (Review)
Allen, M. D., & Jones, J. L. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3075 · Cited by 74
Adult adipose-derived stem cells and breast cancer: a controversial relationship
Bielli, A., Scioli, M. G., Gentile, P., Agostinelli, S., Tarquini, C., Cervelli, V., & Orlandi, A. (2014) · SpringerPlus · doi:10.1186/2193-1801-3-345 · Cited by 75
“These signals are capable to induce the recruitment of several cells types including MSCs, so promoting cancer growth, metastasis and tumour stroma formation (Kucerova et al. 2013; Karnoub et al. 2007).”
BackgroundPrognostic Significance in Breast Cancer of a Gene Signature Capturing Stromal PDGF Signaling
Frings, O., Augsten, M., Tobin, N. P., Carlson, J. W., Paulsson, J., Peña, C., Olsson, E., Veerla, S., Bergh, J. C. S., Östman, A., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.02.018 · Cited by 74
Oncologic Risks of Autologous Fat Grafting to the Breast
Fraser, J. K., Hedrick, M. H., & Cohen, S. R. (2011) · Aesthetic Surgery Journal · doi:10.1177/1090820x10390922 · Cited by 74
Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas
Parker Kerrigan, B. C., Shimizu, Y., Andreeff, M., & Lang, F. F. (2017) · Cytotherapy · doi:10.1016/j.jcyt.2017.02.002 · Cited by 70
Back to the future: Moving beyond “mesenchymal stem cells”
Bianco, P. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23103 · Cited by 73
Mammary Adipose Tissue Control of Breast Cancer Progression: Impact of Obesity and Diabetes
D’Esposito, V., Ambrosio, M. R., Giuliano, M., Cabaro, S., Miele, C., Bèguinot, F., & Formisano, P. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01554 · Cited by 73
“BC cells prompt BM-MSCs to secrete large amount of CCL5, which, in turn, were shown to increase BC metastatic potential of about 5 fold (58).”
BackgroundmiR-223 Is a Coordinator of Breast Cancer Progression as Revealed by Bioinformatics Predictions
Pinatel, E., Orso, F., Penna, E., Cimino, D., Elia, A. R., Circosta, P., Dentelli, P., Brizzi, M. F., Provero, P., & Taverna, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084859 · Cited by 73
“Stroma composition and tumor-stroma interaction and coevolution have been found to mediate cancer progression based on chemokine and hormone secretion [18], as well as on exosome or microvesicle production [19,20].”
BackgroundMesenchymal Stem Cells in Osteoarticular Diseases
Jørgensen, C., & Noël, D. (2011) · Regenerative Medicine · doi:10.2217/rme.11.80 · Cited by 74
Aquino, J. B., Bolontrade, M. F., García, M. G., Podhajcer, O. L., & Mazzolini, G. D. (2010) · Gene Therapy · doi:10.1038/gt.2010.10 · Cited by 73
Mesenchymal Stem Cells and Their Cell Surface Receptors
Docheva, D., Haasters, F., & Schieker, M. (2008) · Current Rheumatology Reviews · doi:10.2174/157339708785133479 · Cited by 73
“Recently, the group of Weinberg [28], has demonstrated that MSCs can greatly increase the metastatic potency of breast carcinoma cells.”
BackgroundCellular Kinetics of Perivascular MSC Precursors
Chen, W. C. W., Park, T. S., Murray, I. R., Zimmerlin, L., Lazzari, L., Huard, J., & Péault, B. (2013) · Stem Cells International · doi:10.1155/2013/983059 · Cited by 66
“Bone marrow (BM) harbors multiple types of stem/progenitor cells, including hematopoietic stem cells (HSCs), endothelial progenitor cells (EPCs), and BM-MSCs [26, 27].”
BackgroundInfluentialThe fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis
Xu, K., Tian, X., Oh, S. Y., Movassaghi, M., Naber, S. P., Kuperwasser, C., & Buchsbaum, R. J. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0674-8 · Cited by 73
“875E-5 [54].”
Boufraqech, M., Zhang, L., Nilubol, N., Sadowski, S. M., Kotian, S., Quezado, M., & Kebebew, E. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2461 · Cited by 73
“Communications between cancer cells and their stromal cells play a central role in tumorigenesis and cancer metastasis by creating a microenvironment that supports angiogenesis and cancer cell invasion and migration (46, 47).”
Yun, Y. I., Park, S. Y., Lee, H. J., Ko, J. H., Kim, M. K., Wee, W. R., Reger, R. L., Gregory, C. A., Choi, H., Fulcher, S. F. A., et al. (2016) · Cytotherapy · doi:10.1016/j.jcyt.2016.10.007 · Cited by 73
Targeting stem cells in the realm of drug-resistant breast cancer
Dey, P., Rathod, M., & De, A. (2019) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s189224 · Cited by 74
“95 BCs have the tendency to recruit mesenchymal cells from the normal breast stroma 96 or from the bone marrow.”
BackgroundThe Role of MSCs in the Tumor Microenvironment and Tumor Progression
Ahn, S. Y. (2020) · Anticancer Research · doi:10.21873/anticanres.14284 · Cited by 73
Shen, Y., Xue, C., Li, X., Ba, L., Gu, J., Sun, Z., Han, Q., & Zhao, R. C. (2019) · Stem Cells and Development · doi:10.1089/scd.2018.0125 · Cited by 72
“Studies have shown that tumor cell-induced MSCs recruit macrophages [25], and they can support tumor growth [26–28].”
Ritter, A., Kreis, N., Hoock, S. C., Solbach, C., Louwen, F., & Yuan, J. (2022) · Cancers · doi:10.3390/cancers14163908 · Cited by 73
“The proteolytic degradation of ECM generates bioactive matrikines and releases matrix-bound VEGF, supporting the growth, migration, and metastasis of cancer cells [196].”
BackgroundInfluentialEffects of microenvironment and biological behavior on the paracrine function of stem cells
Xue, Z., Liao, Y., & Li, Y. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.03.013 · Cited by 72
“As early as 2007, studies confirmed that contact between MSCs and breast cancer cells (BCCs) in the breast cancer environment increased the secretion of CCL5 and SDF-1a and the metastatic potential of cancer cells.(23) In addition, upon contact with tumor cells, MSCs can reversely transfer nucleic acids to these cells…”
ResultSenescent mesenchymal stem cells promote colorectal cancer cells growth via galectin-3 expression
Li, Y., Xu, X., Wang, L., 刘广金, Li, Y., 吴小兵, 荆永光, Li, H., & Wang, G. (2015) · Cell & Bioscience · doi:10.1186/s13578-015-0012-3 · Cited by 72
“[19] showed that MSCs play a pivotal role in colon cancer progression and metastasis; when recruited into breast cancer stroma, bone marrow MSCs tended to facilitate breast cancer cell metastasis and regulate cancer stem cell behavior via the secretion of the chemokine CCL5.”
BackgroundCancer cells suppress p53 in adjacent fibroblasts
Bar, J., Feniger-Barish, R., Lukashchuk, N., Shaham, H., Moskovits, N., Goldfinger, N., Simansky, D., Perlman, M., Papa, M., Yosepovich, A., et al. (2009) · Oncogene · doi:10.1038/onc.2008.445 · Cited by 60
“Normal resident fibroblasts converted into cancer-associated fibroblasts (CAFs) (Elenbaas and Weinberg, 2001), or bone-marrow-derived mesenchymal stem cells may contribute to the stromal compartment (Karnoub et al., 2007).”
BackgroundSo, K. A., Min, K., Hong, J. H., & Lee, J. K. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3122 · Cited by 72
Bone Marrow–Derived Mesenchymal Stromal Cells Promote Survival and Drug Resistance in Tumor Cells
Bergfeld, S. A., Blavier, L., & DeClerck, Y. A. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0400 · Cited by 63
“Karnoub and colleagues found that coinjection of human mammary carcinoma xenografts with BMMSC increased the metastatic spread of tumor cells (37), an effect linked to the production of CCL5 by BMMSC, while”
BackgroundLiu, M., Zhou, J., Chen, Z., & Cheng, A. S. L. (2016) · The Journal of Pathology · doi:10.1002/path.4832 · Cited by 73
Cellular organization and molecular differentiation model of breast cancer-associated fibroblasts
Busch, S., Andersson, D., Bom, E., Walsh, C., Ståhlberg, A., & Landberg, G. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0642-7 · Cited by 72
“It has previously been demonstrated that fibroblastic cells within the tumour stroma possess mesenchymal stem cell (MSC) qualities and that breast cancer cells stimulate secretion of CCL5, which in turn facilitates its metastatic capacity [12].”
Selective isolation and noninvasive analysis of circulating cancer stem cells through Raman imaging
Cho, H., Hossain, M. K., Lee, J., Han, J., Lee, H. J., Kim, K.-J., Kim, J., Lee, K., & Choi, J. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.11.049 · Cited by 72
“We speculated that this result might be due to the basal type cell line MDA-MB-231 showing a subpopulation of more than 90% CD44+/CD24-/low, which is indicative of prospective CSCs which have high tumorigenicity (Cheang et al., 2008; Fillmore and Kuperwasser, 2008; Karnoub et al., 2007).”
BackgroundLuetzkendorf, J., Mueller, L. P., Mueller, T., Caysa, H., Nerger, K., & Schmoll, H. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00794.x · Cited by 72
“However, tumour integration [7, 38, 39] and even proliferation [8] of systemically applied MSC was seen in s.”
BackgroundIL-17 Signaling in the Tumor Microenvironment
Gorczynski, R. M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38315-2_4 · Cited by 71
Stem cells in human breast cancer.
Oliveira, L. R., Jeffrey, S. S., & Ribeiro‐Silva, A. (2010) · PubMed · doi:10.14670/hh-25.371 · Cited by 71
“According to Karnoub et al. (2007), this metastatic capacity is reversible and depends on CCL5 signalling through the chemokine receptor CCR5.”
BackgroundLi, L., Dragulev, B. P., Zigrino, P., Mauch, C., & Fox, J. W. (2009) · International Journal of Cancer · doi:10.1002/ijc.24463 · Cited by 71
“For example, coinjection of bone marrow-derived mesenchymal stem cells enhanced the metastatic potency of MDA-MD-231 human breast carcinoma cells growing at subcutaneous sites via upregulating CCL5-CCR5 signaling.(31) Overexpression of CXCL14 and CXCL12 chemokines in breast cancer-associated myoepithelial cells and my…”
BackgroundScheibe, F., Klein, O., Klose, J., & Priller, J. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-012-9798-2 · Cited by 71
“Moreover, MSCs secrete cytokines like interferon-gamma, tumor necrosis factor-alpha, transforming growth factorbeta (TGF-b), and interleukin (IL)-6 (Karnoub et al. 2007).”
BackgroundBi-Directional Signaling: Extracellular Matrix and Integrin Regulation of Breast Tumor Progression
Gehler, S., Ponik, S. M., Riching, K. M., & Keely, P. J. (2013) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.2013006647 · Cited by 73
“The stromal environment consists of many cell types, including fibroblasts, macrophages, and endothelial cells, in addition to various extracellular matrix (ECM) proteins that function to support normal tissue maintenance, but have also been implicated in tumor progression (2).”
BackgroundImmune Modulation by Mesenchymal Stem Cells
Bifari, F., Lisi, V., Mimiola, E., Pasini, A., & Krampera, M. (2008) · Transfusion Medicine and Hemotherapy · doi:10.1159/000128968 · Cited by 64
Kubow, K. E., Klotzsch, E., Smith, M. L., Gourdon, D., Little, W. C., & Vogel, V. (2009) · Integrative Biology · doi:10.1039/b914996a · Cited by 66
Role of MUC4–NIDO domain in the MUC4-mediated metastasis of pancreatic cancer cells
Senapati, S., Gnanapragassam, V. S., Moniaux, N., Momi, N., & Batra, S. K. (2011) · Oncogene · doi:10.1038/onc.2011.505 · Cited by 71
“Furthermore, several recent reports have demonstrated extravasation as a key step of cancer metastasis that is regulated by a variety of secreted or cell surface proteins (Karnoub et al., 2007; Ma et al., 2008).”
BackgroundEmerging Therapeutic Targets in Breast Cancer Bone Metastasis
Rose, A. A. N., & Siegel, P. M. (2009) · Future Oncology · doi:10.2217/fon.09.138 · Cited by 72
“These cells have been reported by several groups to migrate from the bone mar row into the primary tumor to facilitate growth and local invasion [33,34].”
BackgroundNaxerova, K., Bult, C. J., Peaston, A. E., Fancher, K. S., Knowles, B. B., Kasif, S., & Kohane, I. S. (2008) · Genome biology · doi:10.1186/gb-2008-9-7-r108 · Cited by 71
“For instance, mesenchymal stem cells in the tumor stroma are able to increase breast cancer cell motility through paracrine CCL5 signaling [23].”
BackgroundInvolvement of Mesenchymal Stem Cells in Cancer Progression and Metastases
Chang, A., Schwertschkow, A., Nolta, J., & Wu, J. (2015) · Current Cancer Drug Targets · doi:10.2174/1568009615666150126154151 · Cited by 63
“metastatic breast cancer cell line MDA-MB-231) [11].”
BackgroundCancer Microenvironment: What Can We Learn from the Stem Cell Niche
Lacina, L., Plzák, J., Kodet, O., Szabó, P., Chovanec, M., Dvořánková, B., & Smetana, K. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161024094 · Cited by 71
“Mesenchymal stem cells (MSCs) as a possible source of CAFs were hypothesized; MSCs stimulate breast tumor growth and metastases in mouse graft experiment [100].”
Tang, S., Xiang, T., Huang, S., Zhou, J., Wang, Z., Xie, R., Long, H., & Zhu, B. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.034 · Cited by 71
Breast tumor stroma: A driving force in the development of resistance to therapies
Majidinia, M., & Yousefi, B. (2017) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12893 · Cited by 68
Liu, C., Feng, X., Wang, B., Wang, X., Wang, C., Yu, M., Cao, G., & Wang, H. (2017) · Cancer Science · doi:10.1111/cas.13479 · Cited by 71
“A number of studies have shown that BMMSC play important roles in tumor progression and promote invasion and metastasis in various cancers.(13,14) In the tumor microenvironment, upon interaction with MSC, breast cancer cells showed altered biological functions of certain gene clusters, hence increasing stemness of tum…”
BackgroundJavan, M. R., Khosrojerdi, A., & Moazzeni, S. M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00840 · Cited by 67
“Moreover, MSCs from prostate cancer and breast cancer cell lines overexpress CCL5, which in turn up-modulated the expression of genes involved in EMT, such as zinc finger E-box-binding homeobox 1, CXCR4, and Snail (76, 85).”
BackgroundCCR5-Mediated Signaling is Involved in Invasion of Glioblastoma Cells in Its Microenvironment
Novak, M., Krajnc, M. K., Hrastar, B., Breznik, B., Majc, B., Mlinar, M., Rotter, A., Porčnik, A., Mlakar, J., Stare, K., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124199 · Cited by 71
“CCL5 paracrine signaling was found to promote the migratory, invasive, and metastatic properties of breast cancer cells [24].”
Background
Metadata
- Authors
- Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Weinberg, Robert A.
- Venue
- Nature
- Published
- 2007-10-04
- Volume
- 449
- Issue
- 7162
- Pages
- 557-563
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2141815918
- Cited by
- 3,206
- References
- 36
- Citations by year
- 2026: 41 · 2025: 69 · 2024: 95 · 2023: 137 · 2022: 144 · 2021: 186 · 2020: 192 · 2019: 153 · 2018: 145 · 2017: 176 · 2016: 182 · 2015: 222 · 2014: 232 · 2013: 232 · 2012: 216
- FWCI
- 89.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (P50CA089393, R01CA116235)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Keywords
- mesenchymal stem cells, breast cancer metastasis, tumor stroma, RANTES, CCR5, paracrine signaling, tumor cell motility, tumor invasion, tumor microenvironment, bone marrow-derived stem cells, tumor xenografts
- MeSH terms
- Animals, Breast Neoplasms, Cell Movement, Fibroblasts, Humans, Lung Neoplasms, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasm Transplantation, Mice, SCID, Mice, Inbred NOD, Stromal Cells, Carcinoma, Ductal, Breast, Chemokine CCL5, Receptors, CCR5, Chemokines, CC, Paracrine Communication, Mesenchymal Stem Cell Transplantation, Cell Line, Tumor, Mice, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.